By inhibiting activation of the JNK signalling pathway, isorhynchophylline (IRN) improves cognitive function by reducing Aβ production and deposition, tau protein hyperphosphorylation, and neuroinflammation and has potential as a pharmacological treatment aiming to prevent further progression to AD [188]. Here, MAPT is linked to Alzheimer disease.